<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>Chandra Mani Kafle</title>
    <link rel="stylesheet" href="style.css">
</head>

<body>

<header>
    <h1>Chandra Mani Kafle</h1>
</header>

<main>
    <p>
        I am a biomedical researcher.
    </p>

    <p>
        I study the functional and molecular implications of cancer-associated mutations in a
        critical tumor suppressor. I use biochemical and molecular biology approaches to investigate
        the molecular landscape of one of the common hotspot mutations seen in endometrial cancers.
    </p>

    <ul>
        <li>
            <strong>(Conference proceeding) Kafle CM</strong>, Bell DW.
            Investigation of the mechanism of PADI2 regulation by the FBXW7 tumor suppressor.
            <i>Clinical Cancer Research</i>, 2024.
            <a href="https://doi.org/10.1158/1557-3265.ENDO24-B007">DOI</a>
        </li>
    </ul>

    <p>
        Prior to this, I studied Adenovirus-induced cellular DNA damage response, cell cycle, and DNA
        replication. The findings from my work show that Ad-induction of DDR is necessary for the
        activation of G2/M checkpoint kinases in E4-mutant infected cells. We also showed that
        E4-mutant infected cells are arrested at a phase characterized by either 4N or &gt;4N DNA
        content while preventing cells from going through mitosis.
    </p>

    <ul>
        <li>
            <strong>Kafle CM</strong>, Anderson AY, Prakash A, Swedik S, Bridge E.
            An Adenovirus early region 4 deletion mutant induces G2/M arrest via ATM activation
            and reduces mitotic marker expression.
            <i>Virology</i>, 2021.
            <a href="https://pubmed.ncbi.nlm.nih.gov/34626906/">PMID: 34626906</a>
        </li>
    </ul>

    <p>
        I have also investigated the efficacy of artemisinin- and lumefantrine-based combination
        therapy (ACT) in treating <i>Plasmodium falciparum</i> malaria in Nepal. This multi-institutional
        collaborative work was warranted by the emergence of artemisinin resistance and the detection
        of resistance-associated Kelch 13 (K13) mutations in infected patients in the Greater Mekong
        subregion. We conducted a therapeutic efficacy study in falciparum malaria patients treated
        with ACT in regions with high mobility of migrant workers.
    </p>

    <ul>
        <li>
            Ghimire P, Rijal KR, <strong>Kafle CM</strong>, et al.
            Efficacy of artemether-lumefantrine for treating
            <i>Plasmodium falciparum</i> malaria in Nepal.
            <i>Tropical Diseases, Travel Medicine and Vaccines</i>, 2018.
            <a href="https://pubmed.ncbi.nlm.nih.gov/30123520/">PMID: 30123520</a>
        </li>

        <li>
            <strong>Kafle CM</strong>, Ghimire S, Dhakal P, Shrestha U.
            Identification of parasites in soil samples of vegetable fields in Bhaktapur District.
            <i>Tribhuvan University Journal of Microbiology</i>, 2014.
        </li>
    </ul>

    <p>
        I occasionally write for local magazines and newspapers, and take photographs during my
        hikes and walks.
    </p>
</main>

<footer>
    Â© Chandra Mani Kafle
</footer>

</body>
</html>
